Segment Information (Tables)

12 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information by Segment

The following presents certain segment information as of and for the years ended December 31, 2020 and 2019:

Sale of product	2020		2019
Radiochemical products	$	4,071,571	$	2,852,207
Cobalt products		1,225,580		846,404
Nuclear medicine standards		3,673,256		3,925,303
Radiological services		216,139		1,170,790
Fluorine products		178,350		160,500
Total segments		9,364,896		8,955,204
Corporate revenue		—		—
Total consolidated	$	9,364,896	$	8,955,204

Depreciation and amortization	2020		2019
Radiochemical products	$	42,844	$	38,097
Cobalt products		35,046		8,062
Nuclear medicine standards		62,493		63,691
Radiological services		32,830		34,545
Fluorine products		114,018		113,833
Total segments		287,231		258,228
Corporate depreciation and amortization		12,889		9,805
Total consolidated	$	300,120	$	268,033

Segment income (loss)	2020			2019
Radiochemical products	$	3,966,714		$	820,766
Cobalt products		302,720			201,174
Nuclear medicine standards		580,236			670,133
Radiological services		58,369			(146,922	)
Fluorine products		35,454			9,465
Total segments		4,943,493			1,554,616
Corporate loss		(2,740,842	)		(3,077,580	)
Total consolidated	$	2,202,651		$	(1,522,964	)

Expenditures for segment assets	2020		2019
Radiochemical products	$	2,608,919	$	25,873
Cobalt products		—		172,940
Nuclear medicine standards		—		7,700
Radiological services		—		—
Fluorine products		1,565		1,589
Total segments		2,610,484		208,102
Corporate purchases		5,179		—
Total consolidated	$	2,615,663	$	208,102

Segment assets	2020		2019
Radiochemical products	$	2,916,442	$	511,381
Cobalt products		743,127		3,369,828
Nuclear medicine standards		2,052,220		2,111,225
Radiological services		60,696		106,374
Fluorine products		5,371,506		5,477,808
Total segments		11,143,991		11,576,616
Corporate assets		5,952,758		3,680,179
Total consolidated	$	17,096,749	$	15,256,795